Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SMARAGD - Clinical Research Platform on Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancer Treatment and Outcomes

NCT05129969 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT05129969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05129969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SMARAGD - Clinical Research Platform on Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancer Treatment and Outcomes
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Recruiting
Start date
November 25, 2021
Completion date
December 31, 2030
Enrollment
1,975 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, carcinoma, ovarian, endometrial cancer, endometrial neoplasms, neoplasm, ovarian, ovarian cancer, ovary neoplasm